Abstract:Objective To determine whether curcumin synergizes with doxorubicin hydrochloride to induce the death of autophagic cellsand promote doxorubicin hydrochloride-induced apoptosis in 4T1breast cancer cells. Methods The 4T1 mouse breast cancer cell line was used as the study object.The mice were divided into a control group（PBS）, a curcumin group(10 μmol·L -1 curcumin), a doxorubicin hydrochloride group(10 μmol·L -1 doxorubicin hydrochloride), and a combination group(10 μmol·L -1 curcumin + 10 μmol·L -1 doxorubicin hydrochloride). The cytotoxicity of different treatments to 4T1 cells was compared with CCK-8 assay. Apoptosis induced by different treatments was detected with apoptosis detection kit. CCK-8 assay and autophagy inhibition strategy [co-treatment with 3-methyladenosine（3MA）] were used to determine the induction of autophagic cell death. Immunofluorescence technology was used to study the expression of autophagy-related proteins（LC3 and P62） and immunogenic death-related proteins（CRT and HMGB 1） in different treatment groups. To evaluate the extent of immunogenic cell death, ATP secretion of 4T1 cells in different groups was investigated with the ATP assay kit. The effect of different treatments on the phagocytosis and uptake of the dying tumor cells by bone marrow-derived macrophages（BMDCs）and the effect on MCH-Ⅱ expression of BMDCs were determined by flow cytometry. Results CCK-8 showed that curcumin did not obviously induce the cytotoxicity and apoptosis, but the combination of curcumin with doxorubicin hydrochloride significantly enhanced the level of cytotoxicity and cell apoptosis compared with that of doxorubicin hydrochloride alone. After co-incubation with autophagy inhibitor 3MA, the synergistic effect in the combination group disappeared and the cytotoxicity declined. Compared with the control group, the LC3 expression level was significantly increased and the P62 expression was decreased significantly in the combination group. The immunofluorescence showed that curcumin treatment failed to induce the death of immunogenic cells. The CRT expression and HMGB1 release in the doxorubicin hydrochloride group and the combination group were not significantly different, but the level of ATP release was significantly increased in the combined application group. The flow cytometic results showed that the 4T1 cells in the combined application group were engulfed more by BMDCs compared with in the doxorubicin hydrochloride group,and significantly induced more MCH-Ⅱ expression on the surface of BMDCs. Conclusion The synergistic effect of curcumin and doxorubicin hydrochloride is related to the induction of apoptosis of autophagic cells, which promotes the release of ATP from dying tumor cells, and enhances the phagocytic uptake of dying tumor cells by BMDCs.

Synergistic chemopreventive effects of curcumin and berberine on human breast cancer cells through induction of apoptosis and autophagic cell death

Synergistic Apoptosis-Inducing Effects on A375 Human Melanoma Cells of Natural Borneol and Curcumin

Curcumin enhances the anti-cancer efficacy of paclitaxel in ovarian cancer by regulating the miR-9-5p/BRCA1 axis

Epigallocatechin-3-gallate potentiates the effect of curcumin in inducing growth inhibition and apoptosis of resistant breast cancer cells.

Cellular Effect of Curcumin and Citral Combination on Breast Cancer Cells: Induction of Apoptosis and Cell Cycle Arrest

Synergistic Effect of Cucurbitacin B in Combination with Curcumin Via Enhancing Apoptosis Induction and Reversing Multidrug Resistance in Human Hepatoma Cells.

Curcumin Induces Cell Death And Restores Tamoxifen Sensitivity In The Antiestrogen-Resistant Breast Cancer Cell Lines Mcf-7/Lcc2 And Mcf-7/Lcc9

In-vitro and In-Vivo Anti-Breast Cancer Activity of Synergistic Effect of Berberine and Exercise Through Promoting the Apoptosis and Immunomodulatory Effects.

Potentiation of paclitaxel activity by curcumin in human breast cancer cell by modulating apoptosis and inhibiting EGFR signaling

Synergistic antitumor effect of curcumin combined with doxorubicin hydrochloride on breast cancer cells and related mechanism

Combining luteolin and curcumin synergistically suppresses triple-negative breast cancer by regulating IFN and TGF-β signaling pathways

Synergistic Effects of Curcumin with Emodin Against the Proliferation and Invasion of Breast Cancer Cells Through Upregulation of Mir-34A

Synergistic effect of the anti-PD-1 antibody with blood stable and reduction sensitive curcumin micelles on colon cancer

Enhanced apoptotic effects by the combination of curcumin and methylseleninic acid: potential role of Mcl-1 and FAK.

Modulation of apoptosis-related cell signalling pathways by curcumin as a strategy to inhibit tumor progression

Anticancer effect of curcumin inhibits cell growth through miR-21/PTEN/Akt pathway in breast cancer cell

Integrated Transcriptome and Molecular Docking to Identify the Hub Superimposed Attenuation Targets of Curcumin in Breast Cancer Cells

Study on antihepatocellular carcinoma effect of 6-shogaol and curcumin through network-based pharmacological and cellular assay

Curcumin Enhances the Antitumor Effect of Abt-737 Via Activation of the Ros-Ask1-Jnk Pathway in Hepatocellular Carcinoma Cells

Combination effect of curcumin with docetaxel on the PI3K/AKT/mTOR pathway to induce autophagy and apoptosis in esophageal squamous cell carcinoma.

Evaluation of Efficacy of Curcumin and Caffeic Acid Phenethyl Ester in Breast Cancer by Preclinical Studies